{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:36Z","timestamp":1765609236846,"version":"3.48.0"},"reference-count":52,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["01EA2001B"],"award-info":[{"award-number":["01EA2001B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,5]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Fibromyalgia syndrome (FMS) is defined as a medical condition with chronic widespread musculoskeletal pain accompanied by mood disorders, fatigue and sleep disturbances. Treatment of this condition can often be challenging. As nutrition in general and nutritional interventions in the context of illness management become more and more important, current research also focuses on the relevance of diets for FMS, including gluten as field of interest. To date, there is no clear evidence that a gluten-free diet or other nutritional interventions are significantly important for the reduction of pain in the context of FMS. Only a very few studies show that FMS patients respond to a gluten-free diet and that cytokine production (also in FMS) can be reduced through the change. However, these studies have not investigated whether and to what extent cognitive factors, such as the expectation of symptom reduction triggered by diet, play a role. Recent research shows that treatment expectation plays an important role in the course of the disease and in the effectiveness of treatment approaches. For example, there are promising pain treatment options using open-label placebos (OLPs), which show that expectation alone, rather than the pharmacological substance of medication, can reduce pain experience. In our study protocol, we hypothesise that treatment expectation can be positively influenced by the given information regarding the placebos, resulting in improved treatment outcomes for pain and indigestions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In this trial, patients with FMS will undergo a food challenge and take an OLP (patients will be informed about the placebo), followed by a 3-week OLP treatment. The subjects will be randomised into four groups: (a) gluten-free porridge+neutral\u2009OLP instructions; (b) gluten-free porridge+positive\u2009OLP instructions; (c) gluten-containing porridge+neutral\u2009OLP instructions and (d) gluten-containing porridge+positive\u2009OLP instructions. Patients will be recruited via different institutions and support groups in Hamburg. The inclusion criteria are (a) diagnosed FMS, (b) absence of wheat allergy, coeliac disease or pain-related red flags and (c) being a minimum age of 18 years. The study requires 100 subjects to assess the primary outcomes: pain intensity and occurence of indigestion. Secondary outcomes are functional capacity, treatment expectation, and different pain-related and inflammation-related blood parameters. The measure time points will be before and after the food challenge and before and after the 3-week OLP treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained in October 2021 from the Hamburg Medical Ethics Council. The results of the study will be disseminated through publications, presentations and conference meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>German Clinical Trials Register (DRKS; DRKS00027130).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-074957","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T08:21:13Z","timestamp":1697876473000},"page":"e074957","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Can open label placebos improve pain and gluten tolerance via open label placebos in fibromyalgia patients? A study protocol for a randomised clinical trial in an outpatient centre"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-3447","authenticated-orcid":false,"given":"Lena","family":"Paschke","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[{"name":"Allergology and Immunology, Charite Universitatsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Klinger","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"2025121222504659000_13.10.e074957.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23828"},{"key":"2025121222504659000_13.10.e074957.2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/BOR.0000000000000464","article-title":"The complexities of Fibromyalgia and its Comorbidities","volume":"30","author":"Lichtenstein","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2025121222504659000_13.10.e074957.3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1155\/2010\/354868","article-title":"Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude","volume":"15","author":"Hayes","year":"2010","journal-title":"Pain Res Manag"},{"key":"2025121222504659000_13.10.e074957.4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2013\/742510","article-title":"Patients' and professionals' views on managing Fibromyalgia","volume":"18","author":"Briones-Vozmediano","year":"2013","journal-title":"Pain Res Manag"},{"key":"2025121222504659000_13.10.e074957.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.19.2388"},{"key":"2025121222504659000_13.10.e074957.6","unstructured":"Zum Ern\u00e4hrungsverhalten T-S. ISS was, Deutschland?"},{"key":"2025121222504659000_13.10.e074957.7","unstructured":"Statista . Gluten-free and free-from food retail sales in the United States from 2006 to 2020 (in billion US dollars). 2013."},{"key":"2025121222504659000_13.10.e074957.8","unstructured":"Statista . Anzahl der Personen in Deutschland, die Innerhalb der Letzen 14 Tage Glutenfreie Lebensmittel Gekauft Haben, von 2018 BIS 2022 (in Millionen). 2022. Available: https:\/\/de.statista.com\/statistik\/daten\/studie\/452635\/umfrage\/umfrage-in-deutschland-zum-konsum-glutenfreier-lebensmittel\/#:~:text=Umfrage%20in%20Deutschland%20zum%20Konsum%20glutenfreier%20Lebensmittel%20bis%202022&text=Im%20Jahr%202022%20gab%20es,Tagen%20glutenfreie%20Lebensmittel%20gekauft%20hatten"},{"key":"2025121222504659000_13.10.e074957.9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/1744666X.2021.1880320","article-title":"An updated overview on celiac disease: from Immuno-pathogenesis and Immuno-Genetics to therapeutic implications","volume":"17","author":"D\u2019Avino","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"2025121222504659000_13.10.e074957.10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-9-49","article-title":"Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study","volume":"9","author":"Vilppula","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"2025121222504659000_13.10.e074957.11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2020.06.098","article-title":"Epidemiology, presentation, and diagnosis of celiac disease","volume":"160","author":"Lebwohl","year":"2021","journal-title":"Gastroenterology"},{"key":"2025121222504659000_13.10.e074957.12","doi-asserted-by":"crossref","unstructured":"Choung RS , Unalp-Arida A , Ruhl CE , et al . Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the national health and nutrition examination surveys from 2009 to 2014. Mayo Clin Proc 2016:S0025-6196(16)30634-6. doi:10.1016\/j.mayocp.2016.10.012","DOI":"10.1016\/j.mayocp.2016.10.012"},{"key":"2025121222504659000_13.10.e074957.13","unstructured":"Niland B , Cash BD . Health benefits and adverse effects of a gluten-free diet in non-celiac disease patients. Gastroenterol Hepatol 2018;14."},{"key":"2025121222504659000_13.10.e074957.14","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2014.869996"},{"key":"2025121222504659000_13.10.e074957.15","doi-asserted-by":"crossref","DOI":"10.3390\/medicina55060222","article-title":"Non-celiac gluten sensitivity: A review","volume":"55","author":"Roszkowska","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"2025121222504659000_13.10.e074957.16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MOG.0000000000000248","article-title":"From coeliac disease to Noncoeliac gluten sensitivity; should everyone be gluten free","volume":"32","author":"Aziz","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"2025121222504659000_13.10.e074957.17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/keac434","article-title":"Prevalence of non-celiac gluten sensitivity and assessment of the response to gluten-free diet in a cohort of patients with Fibromyalgia","volume":"62","author":"Almirall","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025121222504659000_13.10.e074957.18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00296-014-2990-6","article-title":"Fibromyalgia and non-celiac gluten sensitivity: a description with remission of Fibromyalgia","volume":"34","author":"Isasi","year":"2014","journal-title":"Rheumatol Int"},{"key":"2025121222504659000_13.10.e074957.19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.reuma.2014.06.005","article-title":"Fibromyalgia and chronic fatigue syndrome caused by non-celiac gluten sensitivity","volume":"11","author":"Isasi","year":"2015","journal-title":"Reumatol Clin"},{"key":"2025121222504659000_13.10.e074957.20","article-title":"Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus Fibromyalgia in patients with associated lymphocytic Enteritis: a case-control study","volume":"16","author":"Rodrigo","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025121222504659000_13.10.e074957.21","first-page":"211","article-title":"Effect of the gluten-free diet on quality of life, gastrointestinal symptoms and immune system in patients with Fibromyalgia and non-celiac wheat sensitivity. Fibromyalgia and non-celiac wheat sensitivity","volume":"4","author":"Schinocca","year":"2021","journal-title":"J Biotechnol Biomed"},{"key":"2025121222504659000_13.10.e074957.22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MCG.0000000000000651","article-title":"The effects of a gluten-free diet versus a Hypocaloric diet among patients with Fibromyalgia experiencing gluten sensitivity-like symptoms: A pilot, open-label randomized clinical trial","volume":"51","author":"Slim","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"2025121222504659000_13.10.e074957.23","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3748\/wjg.v28.i18.1965","article-title":"Effect of ancient Khorasan wheat on gut Microbiota, inflammation, and short-chain fatty acid production in patients with Fibromyalgia","volume":"28","author":"Baldi","year":"2022","journal-title":"WJG"},{"key":"2025121222504659000_13.10.e074957.24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/07315724.2020.1813059","article-title":"Fibromyalgia and nutrition: an updated review","volume":"40","author":"Tomaino","year":"2021","journal-title":"J Am Coll Nutr"},{"key":"2025121222504659000_13.10.e074957.25","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092525","article-title":"Nutritional interventions in the management of Fibromyalgia syndrome","volume":"12","author":"Pagliai","year":"2020","journal-title":"Nutrients"},{"key":"2025121222504659000_13.10.e074957.26","unstructured":"Deutsche Schmerzgesellschaft . Definition, Diagnostik und Therapie des Fibromyalgiesyndroms, Available: http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/145-004.html"},{"key":"2025121222504659000_13.10.e074957.27","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/rheumatology\/keab146","article-title":"Is Fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis","volume":"60","author":"O\u2019Mahony","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025121222504659000_13.10.e074957.28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00482-021-00602-0","article-title":"\u201cSystemic inflammation, \"sickness behavior\" and expectations what role do expectations play in inflammation-associated symptoms\u201d","volume":"36","author":"Schmidt","year":"2022","journal-title":"Schmerz"},{"key":"2025121222504659000_13.10.e074957.29","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001108"},{"key":"2025121222504659000_13.10.e074957.30","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2014.994506"},{"key":"2025121222504659000_13.10.e074957.31","doi-asserted-by":"crossref","unstructured":"Baumeister D , Eich W , Saft S , et al . No evidence for altered plasma NGF and BDNF levels in Fibromyalgia patients. Sci Rep 2019;9. doi:10.1038\/s41598-019-49403-7","DOI":"10.1038\/s41598-019-49403-7"},{"key":"2025121222504659000_13.10.e074957.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00205-1"},{"key":"2025121222504659000_13.10.e074957.33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.pain.2013.12.007","article-title":"Placebo analgesia: clinical applications","volume":"155","author":"Klinger","year":"2014","journal-title":"Pain"},{"key":"2025121222504659000_13.10.e074957.34","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1007\/s10072-006-0580-4","article-title":"Placebo analgesia","volume":"27 Suppl 2","author":"Benedetti","year":"2006","journal-title":"Neurol Sci"},{"key":"2025121222504659000_13.10.e074957.35","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.10251"},{"key":"2025121222504659000_13.10.e074957.36","first-page":"203","article-title":"The Nocebo reaction","volume":"95","author":"Kennedy","year":"1961","journal-title":"Med World"},{"key":"2025121222504659000_13.10.e074957.37","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e3182294a50"},{"key":"2025121222504659000_13.10.e074957.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507063330101"},{"key":"2025121222504659000_13.10.e074957.39","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191610234","article-title":"The perception of Lactose-related symptoms of patients with Lactose Malabsorption","volume":"19","author":"Di Stefano","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025121222504659000_13.10.e074957.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.02.005"},{"key":"2025121222504659000_13.10.e074957.41","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000700"},{"key":"2025121222504659000_13.10.e074957.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: a randomized controlled trial in irritable bowel syndrome","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS ONE"},{"key":"2025121222504659000_13.10.e074957.43","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/j.pain.0000000000000977","article-title":"Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain","volume":"158","author":"Klinger","year":"2017","journal-title":"Pain"},{"key":"2025121222504659000_13.10.e074957.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.012"},{"key":"2025121222504659000_13.10.e074957.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.030"},{"key":"2025121222504659000_13.10.e074957.46","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3923"},{"key":"2025121222504659000_13.10.e074957.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2740-y"},{"key":"2025121222504659000_13.10.e074957.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1169-0"},{"key":"2025121222504659000_13.10.e074957.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.04.192"},{"key":"2025121222504659000_13.10.e074957.50","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246020"},{"key":"2025121222504659000_13.10.e074957.51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192758","article-title":"Why do open-label Placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis","volume":"13","author":"Schaefer","year":"2018","journal-title":"PLoS One"},{"key":"2025121222504659000_13.10.e074957.52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247103","article-title":"\u201cExplaining placebo effects in an online survey study: does 'Pavlov' ring a bell\u201d","volume":"16","author":"Smits","year":"2021","journal-title":"PLoS One"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-074957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:51:02Z","timestamp":1765608662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-074957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,21]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-074957"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-074957","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}